📢Market Bulletin
Product Recalls & Safety Alerts (3)
Category Archive →Medical Device Safety Notice: Ethylene Oxide Sterilization Residual Non-Conformance in Surgical Kits
Regulatory safety notification addressing field recalls of sterile single-use surgical packs and catheters ( HS Code 9018.39 ) due to incomplete Ethylene Oxide (EO) aeration cycles and elevated residual 2-chloroethanol (ECH) concentrations. Biological & Chemical Thresholds: Sterilization lots must pass ISO 11135 validation using Bacillus atrophaeus biological indicators and conform strictly to ISO 10993-7 allowable daily exposure limits for EO and ECH. Quarantine Protocol: Institutional buyers must confirm valid degassing quarantine periods and review third-party gas chromatography residual test reports on import dossiers. Official Source & Verification Reference Issuing Authority: U.S. Food and Drug Administration (FDA) Safety Alerts • Reference: FDA-MED-EO-2026-10 Verify Official Source Document ↗
Global Medical Product Alert: Mandatory DEG/EG Impurity Testing for Oral Liquid Pharmaceutical Excipients
Urgent pharmacovigilance alert reinforcing zero-tolerance screening for Diethylene Glycol (DEG) and Ethylene Glycol (EG) contamination in liquid excipients, including Glycerin ( HS Code 2905.45 ), Propylene Glycol ( HS Code 2905.32 ), and Sorbitol solutions. Mandatory Release Testing: Every incoming drum of liquid excipient must undergo USP Gas Chromatography (GC-FID) limit testing confirming DEG and EG levels strictly ≤ 0.10% prior to compounding. Supply Chain Traceability: Wholesalers are advised to reject unsealed drums or secondary-repackaged excipients lacking original manufacturer Certificates of Analysis (COA) and intact tamper-evident seals. Official Source & Verification Reference Issuing Authority: World Health Organization (WHO) Substandard & Falsified Products Alert • Reference: WHO-MPA-DEG-2026 Verify Official Source Document ↗
Regulatory Recall Advisory: Sub-Visible Particulate Matter & Glass Delamination in Parenteral Vials (USP <788>)
Safety alert issued to hospital pharmacies and parenteral importers regarding voluntary batch recalls triggered by visible particulate matter and inner-surface glass delamination in sterile intravenous solutions ( HS Code 3004.90 ). Compendial Standard: Small-volume parenterals (≤100 mL) must strictly meet USP <788> light obscuration limits (≤6,000 particles ≥10 μm and ≤600 particles ≥25 μm per container). Importer Action: Distributors must verify Type I borosilicate glass hydrolytic resistance certifications (USP <660>) and inspect lot-release 100% automated optical inspection records prior to hospital distribution. Official Source & Verification Reference Issuing Authority: U.S. Food and Drug Administration (FDA) • Reference: FDA-ENF-RECALL-2026-08 Verify Official Source Document ↗
